BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 38.9% – Here’s Why

BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ) shares fell 38.9% on Wednesday . The company traded as low as $0.5805 and last traded at $0.6388. 771,803 shares were traded during trading, a decline of 99% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.0450.

BioRestorative Therapies Stock Down 38.9%

The business’s 50 day simple moving average is $1.12 and its 200 day simple moving average is $1.36. The stock has a market cap of $1.05 billion, a price-to-earnings ratio of -0.60 and a beta of 102.36.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc, which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.

The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials.